Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,137.90
(
1.05%
)
US TECH 100
26,218.00
(
1.73%
)
Dow Jones
49,490.03
(
0.09%
)
Brent Oil
97.63
(
0.94%
)
Bitcoin
78,157.45
(
-0.10%
)
News Focus
News Focus
Post# of 234025
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (7) Keep Next 10 Report Keyboard Shortcuts
Replies (7) Next 10 Prev Next

Jamesripp

Send PM Follow Ignore
Followers 0
Posts 7
Boards Moderated 0
Alias Born 05/19/2015

Jamesripp

Re: shajandr post# 90034

Wednesday, 06/17/2015 12:15:21 AM

Wednesday, June 17, 2015 12:15:21 AM

Post# of 234025
The "failed drug" you refer to (Ampligen) just got designated as an orphan drug to treat Ebola by the European Medicines Agency.

Please check your facts before posting false info that may be detrimental to shareholders' interests. I am large shareholder of HEB and an attorney, and I am not afraid to pursue legal recourse against those spreading false information about this company.
Public Reply Private Reply New Post
Keep Last Read
Replies (7) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (7) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today